Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder

Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research

Jeffrey R. Strawn, Paul E Croarkin

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
Number of pages1
JournalJournal of Child and Adolescent Psychopharmacology
Volume28
Issue number5
DOIs
StatePublished - Jun 1 2018

Fingerprint

Psychopharmacology
Fluoxetine
Major Depressive Disorder
Placebos
Research
Desvenlafaxine Succinate

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

@article{78d736234fe048628e9e97fdd48686c5,
title = "Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research",
author = "Strawn, {Jeffrey R.} and Croarkin, {Paul E}",
year = "2018",
month = "6",
day = "1",
doi = "10.1089/cap.2018.0012",
language = "English (US)",
volume = "28",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder

T2 - Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research

AU - Strawn, Jeffrey R.

AU - Croarkin, Paul E

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85048368487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048368487&partnerID=8YFLogxK

U2 - 10.1089/cap.2018.0012

DO - 10.1089/cap.2018.0012

M3 - Letter

VL - 28

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 5

ER -